1,070
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Acceptance of varicella vaccination

ORCID Icon
Pages 1699-1702 | Received 01 Oct 2020, Accepted 23 Oct 2020, Published online: 16 Dec 2020

References

  • Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10(11). doi:10.3390/v10110609.
  • Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741. doi:10.1542/peds.2015-3741.
  • Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–57. doi:10.1080/21645515.2018.1546525.
  • European Centre of Disease Prevention and Control. ECDC guideance: varicella vaccination in the European Union. 2015.
  • Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics. 2011;127(2):238–45. doi:10.1542/peds.2010-0962.
  • Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71. doi:10.4161/hv.34311.
  • Weinmann S, Irving SA, Koppolu P, Naleway AL, Belongia EA, Hambidge SJ, Jackson ML, Klein NP, Lewin B, Liles E, et al. Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine. Vaccine. 2020;38(37):5880–84. doi:10.1016/j.vaccine.2020.05.006.
  • Varicella and herpes zoster vaccines: WHO position paper, June 2014–Recommendations. Vaccine. 2016;34(2):198–99. doi:10.1016/j.vaccine.2014.07.068.
  • Varicella and herpes zoster vaccines: WHO position paper, June. 2014. Wkly Epidemiol Rec. 2014;89(25):265–87.
  • Meszner Z, Molnar Z, Rampakakis E, Yang HK, Kuter BJ, Wolfson LJ. Economic burden of varicella in children 1–12 years of age in Hungary, 2011–2015. BMC Infect Dis. 2017;17(1):495. doi:10.1186/s12879-017-2575-6.
  • Meszner Z, Wysocki J, Richter D, Zavadska D, Ivaskeviciene I, Usonis V, Pokorn M, Mangarov A, Jancoriene L, Man SC, et al. Burden of varicella in Central and Eastern Europe: findings from a systematic literature review. Expert Rev Vaccines. 2019;18(3):281–93. doi:10.1080/14760584.2019.1573145.
  • McCarthy KN, M CÓ, Butler KM, Gavin PJ. Varicella related hospital admissions in Ireland. Ir Med J. 2019;112:966.
  • Haugnes H, Flem E, Wisløff T. Healthcare costs associated with varicella and herpes zoster in Norway. Vaccine. 2019;37(29):3779–84. doi:10.1016/j.vaccine.2019.05.063.
  • Al Kaabi N, Al Olama F, Al Qaseer M, Al Ubaidani I, Dinleyici EC, Hayajneh WA, Bizri AR, Loulou M, Ndao T, Wolfson LJ, et al. The clinical and economic burden of varicella in the Middle East: a systematic literature review. Hum Vaccin Immunother. 2020;16(1):21–32. doi:10.1080/21645515.2019.1638726.
  • Arlant LHF, Garcia MCP, Avila Aguero ML, Cashat M, Parellada CI, Wolfson LJ. Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review. BMC Public Health. 2019;19(1):528. doi:10.1186/s12889-019-6795-0.
  • Wolfson LJ, Castillo ME, Giglio N, Meszner Z, Molnar Z, Vazquez M, Wysocki J, Altland A, Kuter BJ, Rickard J, et al. Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe. Hum Vaccin Immunother. 2019;15(4):932–41. doi:10.1080/21645515.2018.1559687.
  • Goh AEN, Choi EH, Chokephaibulkit K, Choudhury J, Kuter B, Lee PI, Marshall H, Kim JO, Wolfson LJ. Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Rev Vaccines. 2019;18(5):475–93. doi:10.1080/14760584.2019.1594781.
  • Dubé E, MacDonald NE. How can a global pandemic affect vaccine hesitancy? Expert Rev Vaccines. 2020. doi: 10.1080/14760584.2020.1825944
  • Wutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16(8):833–43. doi:10.1080/14760584.2017.1343669.
  • European Centre for Disease Prevention and Control (ECDC). Vaccine scheduler: vaccine schedules in all countries of the European Union. Sweden, Stockholm: ECDC. [accesed 25 Sept 2020]. https://vaccine-schedule.ecdc.europa.eu.
  • Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing universal varicella vaccination in Europe: the path forward. Pediatr Infect Dis J. 2019;38(2):181–88. doi:10.1097/INF.0000000000002233.
  • Directorate of health of Iceland: information about childhood vaccinations. https://www.landlaeknir.is/servlet/file/store93/item21251/LAN%2093074%20Bolusetningarbkl.enska.pdf
  • Huber A, Gazder J, Dobay O, Mészner Z, Horváth A. Attitudes towards varicella vaccination in parents and paediatric healthcare providers in Hungary. Vaccine. 2020;38(33):5249–55. doi:10.1016/j.vaccine.2020.05.091.
  • Bernal JL, Hobbelen P, Amirthalingam G. Burden of varicella complications in secondary care, England, 2004 to 2017. Eur Communicable Dis Bull. 2019;24(42):1900233
  • Bonanni P, Zanobini P. Universal and targeted varicella vaccination. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30358-3.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.
  • Gust D, Brown C, Sheedy K, Hibbs B, Weaver D, Nowak G. Immunization attitudes and beliefs among parents: beyond a dichotomous perspective. Am J Health Behav. 2005;29(1):81–92. doi:10.5993/AJHB.29.1.7.
  • Ganczak M, Dmytrzyk-Danilow G, Karakiewicz B, Korzen M, Szych Z. Determinants influencing self-paid vaccination coverage, in 0–5 years old Polish children. Vaccine. 2013;31(48):5687–92. doi:10.1016/j.vaccine.2013.09.056.
  • Stokley S, Shaw KM, Barker L, Santoli JM, Shefer A. Impact of state vaccine financing policy on uptake of heptavalent pneumococcal conjugate vaccine. Am J Public Health. 2006;96:1308–13.
  • World Health Organization. Top ten threats to global health in 2019. 2019.
  • Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF joint reporting form data-2015–2017. Vaccine. 2018;36(26):3861–67. doi:10.1016/j.vaccine.2018.03.063.
  • Vezzosi L, Santagati G, Angelillo IF. Knowledge, attitudes, and behaviors of parents towards varicella and its vaccination. BMC Infect Dis. 2017;17(1):172. doi:10.1186/s12879-017-2247-6.
  • van Lier A, Tostmann A, Harmsen IA, de Melker HE, Hautvast JL, Ruijs WL. Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys. BMC Infect Dis. 2016;16:127. doi:10.1186/s12879-016-1442-1.
  • Hagemann C, Streng A, Kraemer A, Liese JG. Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance. BMC Public Health. 2017;17(1):724. doi:10.1186/s12889-017-4725-6.
  • Hu Y, Li Q, Chen Y. Evaluation of two health education interventions to improve the varicella vaccination: a randomized controlled trial from a province in the east China. BMC Public Health. 2018;18(1):144. doi:10.1186/s12889-018-5070-0.
  • Streng A, Seeger K, Grote V, Liese JG. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004. Vaccine. 2010;28(35):5738–45. doi:10.1016/j.vaccine.2010.06.007.
  • Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17(1):353. doi:10.1186/s12879-017-2445-2.
  • Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, V Kries R. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27(2):119–24. doi:10.1097/INF.0b013e3181586665.
  • Duncan JR, Witkop CT, Webber BJ, Costello AA. Varicella seroepidemiology in United States air force recruits: a retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection. Vaccine. 2017;35(18):2351–57. doi:10.1016/j.vaccine.2017.03.054.
  • Tourtelot E, Quataert S, Glantz JC, Perlis L, Muthukrishnan G, Mosmann T. Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels. Vaccine. 2020;38(7):1581–85. doi:10.1016/j.vaccine.2019.12.067.
  • Eberhardt CS, Wieland A, Nasti TH, Grifoni A, Wilson E, Schmid DS, Pulendran B, Sette A, Waller EK, Rouphael N et al. Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccination. J Virol. 2020;94(13):e02127-19.
  • Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS. Varicella immunity in vaccinated healthcare workers. J Clin Virol. 2013;57(2):109–14. doi:10.1016/j.jcv.2013.01.015.
  • Breuer J, Schmid DS, Gershon AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis. 2008;197(Suppl 2):S147–51. doi:10.1086/529448.
  • Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccines. 2017;16(4):391–400. doi:10.1080/14760584.2017.1294069.
  • Woodward M, Marko A, Galea S, Eagel B, Straus W. Varicella virus vaccine live: a 22-year review of postmarketing safety data. Open Forum Infect Dis. 2019;6(8). doi:10.1093/ofid/ofz295.
  • Tokish H, Solanto MV. The problem of vaccination refusal: a review with guidance for pediatricians. Curr Opin Pediatr. 2020;32(5):683–93. doi:10.1097/MOP.0000000000000937.
  • Brownlie J, Howson A. ‘Leaps of faith’ and MMR: an empirical study of trust. Sociology. 2005;39(2):221–39. doi:10.1177/0038038505050536.
  • Sondagar C, Xu R, MacDonald NE, Dubé E. Vaccine acceptance: how to build and maintain trust in immunization. Can Commun Dis Rep. 2020;46(5):155–59. doi:10.14745/ccdr.v46i05a09.
  • Cataldi JR, Kerns ME, O’Leary ST. Evidence-based strategies to increase vaccination uptake: a review. Curr Opin Pediatr. 2020;32(1):151–59. doi:10.1097/MOP.0000000000000843.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.